Company intelligence / Profile preview

Distillery Therapeutics

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Distillery Therapeutics is a biotechnology company focused on discovering and developing novel small molecule therapeutics for oncology and rare diseases. The company utilizes a proprietary drug discovery platform designed to identify and optimize molecules that can modulate challenging biological targets. By leveraging advanced computational tools and chemical biology, Distillery Therapeutics aims to create precision medicines that address significant unmet medical needs. The company is currently in the pre-clinical stage, advancing its internal pipeline toward candidate selection.

Therapeutic areas: Rare DiseasesOncology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Distillery Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Distillery Therapeutics.

Explore the full profile